Literature DB >> 1670953

Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.

A V Juorio1, I A Paterson, M Y Zhu, G Matte.   

Abstract

In rats pretreated with deprenyl (2 mg/kg), electrical stimulation of the left substantia nigra produced an increase in the concentrations of 3,4-dihydroxyphenylacetic acid and homovanillic acid in the left striatum by 57 and 45%, but the levels of 2-phenylethylamine and p-tyramine decreased by 22 and 41%, respectively, as compared with those in the right striatum. The administration of alpha-methyl-p-tyrosine (1.25 mg/kg, i.p.), a tyrosine hydroxylase inhibitor, 1 h before nigral stimulation, did not affect the concentration of 2-phenylethylamine in unstimulated striata but prevented the stimulation-induced decrease in the concentration of 2-phenylethylamine. Neither stimulation nor alpha-methyl-p-tyrosine affected the activity of monoamine oxidase A or B, and stimulation did not produce any change in striatal blood flow, a finding demonstrating that the changes in the rate of accumulation of 2-phenylethylamine were not due to changes in catabolism or removal of 2-phenylethylamine from the brain. These experiments demonstrate that the rate of synthesis of striatal 2-phenylethylamine is decreased following nigral stimulation and that this effect is blocked after partial inhibition of tyrosine hydroxylase. This suggests that 2-phenylethylamine is present in tyrosine hydroxylase-containing neurons and therefore supports the coexistence of 2-phenylethylamine and dopamine in the nigrostriatal pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670953     DOI: 10.1111/j.1471-4159.1991.tb02583.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Decreased beta-phenylethylamine in CSF in Parkinson's disease.

Authors:  G Zhou; H Shoji; S Yamada; T Matsuishi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-12       Impact factor: 10.154

2.  The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions.

Authors:  E Scarr; D M Wingerchuk; A V Juorio; I A Paterson
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

3.  Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats.

Authors:  Lin Chen; Xinbing Wei; Yunfeng Hou; Xiaoqian Liu; Senpeng Li; Baozhu Sun; Xinyong Liu; Huiqing Liu
Journal:  Neurochem Int       Date:  2014-01-22       Impact factor: 3.921

4.  Phenylalanine in the caudate nucleus of dopamine depleted rats.

Authors:  P R Paetsch; A J Greenshaw; A V Juorio
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

Review 5.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

6.  β-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neurons.

Authors:  Murad Hossain; Rochelle N Wickramasekara; Lucia Carvelli
Journal:  Neurochem Int       Date:  2013-10-23       Impact factor: 3.921

Review 7.  Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.

Authors:  Yue Pei; Aman Asif-Malik; Juan J Canales
Journal:  Front Neurosci       Date:  2016-04-05       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.